mbiomics
mbiomics is a bacterial profiling and microbiome analysis platform founded in 2020 by Markus Rinecker, Laura Figulla and Johannes Woehrstein.
Seedtable Score
25
Startups
2
Funding Rounds
$28.0m
Money raised
Overview
mbiomics is a bacterial profiling and microbiome analysis platform founded in 2020 by Markus Rinecker, Laura Figulla and Johannes Woehrstein.
- Website:
- Headquarters: Munich
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| La*** Fi***** | - | - | |
| Ma**** Ri****** | - | - | - |
| Jo****** Wo******** | - | - |
Funding
Funding series
Funding Series Analysis
The company mbiomics has raised a total of $28m in funding over 2 rounds.
Key Insights:
- mbiomics Series A Round, April 2026: $14m
- mbiomics March 2023 Series A Funding Round: $14m
mbiomics Series A Round, April 2026
$14m
mbiomics March 2023 Series A Funding Round
$14m